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Abstract
The Committee of the European Concerted Action for Multiple Sclerosis (Charcot Foundation) organised five workshops to discuss CSF analytical standards in the diagnosis of multiple sclerosis. This consensus report from 12 European countries summarises the results of those workshops. It is hoped that neurologists will confer with their colleagues in clinical chemistry to arrange the best possible local practice. The most sensitive method for the detection of oligoclonal immunoglobulin bands is isoelectric focusing. The same amounts of IgG in parallel CSF and serum samples are used and oligoclonal bands are revealed with IgG specific antibody staining. All laboratories performing isoelectric focusing should check their technique at least annually using "blind" standards for the five different CSF and serum patterns. Quantitative measurements of IgG production in the CNS are less sensitive than isoelectric focusing. The preferred method for detection of blood-CSF barrier dysfunction is the albumin quotient. The There is a voluminous literature on CSF analysis in multiple sclerosis ranging from more fundamental aspects to reported changes with treatment. We thus refer to some selected reviews.2-9 What is of more practical relevance to the neurologist is the role of CSF analysis in helping to make the diagnosis of multiple sclerosis.
Approach to consensus on single topics Delegates were chosen from most European countries with an inclination towards those who had provided a laboratory diagnostic service by CSF analysis. The topics discussed were initially assigned to individual delegates who each prepared a discussion paper on their respective topic of interest. It was also agreed that the relative importance of each recommendation would be assigned to one of three categories of tests: (1) In practical terms we worked through three sequential drafts with each version becoming successively shorter. The principle of consensus then adopted was that if more than two people objected, the relevant statement was dropped. It was not difficult to agree unanimously on isoelectric focusing but there were obvious objections to the use of any one reference as the "chosen" technique. After much discussion about blood-brain and CSF barriers and mathematical formulations that attempt to express quantitative measures of "CNS production of IgG", all agreed that these were not essential (as opposed to isoelectric focusing). There was, however, almost unanimous agreement on non-linear formulations, which in practice would be different in various laboratories. Most other issues were eventually agreed without undue difficulties. 
Diagnosis of multiple sclerosis
(1) Abnormal Normal barrier content of lumbar CSF, it is possible to assess the integrity of the (functionally defined) blood-CSF barrier, but not the isolated blood-brain barrier. In healthy people or in patients without objective signs of neurological disorders, the passage of plasma proteins across the blood-CSF barrier depends on their hydrodynamic radii, which are related to their molecular weights under steady state conditions.1' In such populations the absolute CSF concentrations of specific plasma derived proteins depend on many factors including the serum concentration of each protein, blood-CSF barrier integrity, rate of CSF flow, molecular size of the protein, age of the patient, and the volume of CSF removed. Albumin, the major CSF protein, is synthesised only by hepatocytes and is not catabolised within the CNS. Dynamic studies with intravenously injected radiolabelled albumin'2 have shown that serum is the source of CSF albumin and strongly support the use of CSF/serum albumin quotients (QAlb = CSF albumin/serum albumin) to assess the blood-CSF barrier function.
Another approach'314 is related to the measurement of CSF albumin only: any increase of CSF albumin (above the mean) indicates altered blood-CSF barrier function.
Determination of total CSF protein is less reliable than that of CSF albumin. If total protein is adopted as an alternative to albumin, then the method used should yield a similar optical density/g protein for both albumin and IgG. This is necessary in view of the wide variability of IgG relative to albumin, which can vary between 3% in normal and 30% in abnormal CSF. The IgG ratio (CSF IgG/CSF albumin) is of limited value as a parallel serum specimen should be analysed (see later).
The albumin quotient is age dependent.5 16 The upper reference limit for the first 10 ml of lumbar fluid is 5-0 x 10-3 for patients under 15 years of age; Use of the CSF/serum quotient for IgG reduces variation due to differences in the individual concentrations of serum IgG. By referring this CSF/serum IgG quotient to the CSF/serum albumin quotient it is possible to further reduce the variation of the IgG quotient related to individual differences in blood-CSF barrier function. There are many approaches by which both of these quotients are combined to obtain an expression that will discriminate between the locally synthesised IgG fraction in the brain and the fraction of CSF IgG that is derived from the blood by filtration.
The use of a non-linear relation between the IgG quotient and the albumin quotient is recommended, as a linear approach can lead to a loss of sensitivity when there is blood-CSF barrier dysfunction. '9-22 Another optional test under study is the detection of intrathecal synthesis of specific antibodies (for instance, against the measles virus). These specific antibody tests have gained further clinical relevance through improvement of the sensitivity of the evaluation techniques, mainly by the introduction of extrapolation methods for the locally synthesised fraction of IgG (or IgM), as well as correction for any blood-CSF barrier dysfunction.'4 [24] [25] [26] Of special interest for the diagnosis of multiple sclerosis is the report that polyspecific antibody synthesis against several different viruses can occur in the brain. In one series, local synthesis of antibody to measles, rubella, and/or zoster could be found in the CSF of 94% of patients with multiple sclerosis.26 The relevance of these methods has been partially confirmed by the identification of oligoclonal patterns on isoelectric focusing for each virus (measles, rubella, zoster) by use of the affinity mediated capillary blot technique.27 Also, it has been found that the antibody affinity is different in acute compared with chronic diseases, which further supports the idea that the polyspecific immune response may also become an important tool for diagnosis in multiple sclerosis. 28 For the correct interpretation of the humoral immune response in CSF, it is important to keep in mind that the local IgG, IgA, or IgM synthesis, including any specific antibody synthesis in the brain, might have several origins. It could be due either to a persistent antibody response from an old clinically irrelevant immunological process or to an acute inflammatory process. Local IgG synthesis, detected either by increased IgG quotients, formulae, or by isoelectric focusing, can still be seen many years after adequately treated cases of neurosyphilis or neuroborreliosis, among other examples of an intrathecal immune response. 
ISOELECTRIC FOCUSING OF OLIGOCLONAL IgG
The strongest consensus is that isoelectric focusing is the most sensitive test for the detection of humoral immune responses when using the same amounts of IgG in parallel CSF and serum specimens.1321 27 There must be parallel investigation of serum with a clear comment on the relative band patterns in CSF and serum. Figures 2 and 3 show examples of the five types of patterns.
The banding patterns on isoelectric focusing shown in figure 2 are simplified for purposes of demonstration. Densitometric scanning is not required for interpretation. IgA IgA analysis, either by quantitative or qualitative techniques, is of little value for the laboratory supported diagnosis of multiple sclerosis.
Strong intrathecal IgA production, however, may imply a different diagnosis. Most methods for quantitative analysis of IgA production have so far failed to take into account the relative proportion of monomeric and dimeric IgA in both CSF and serum, although dimeric IgA was shown to be preferentially produced in cases of intrathecal synthesis. 40 As a consequence, amounts of local IgA synthesis could be underestimated depending on the method used. The occurrence of oligoclonal IgA bands on isoelectric focusing in multiple sclerosis or other neurological diseases is uncommon.'9 IgM Determination of CSF IgM by quantitative and qualitative methods to show intrathecal production of IgM are optional tests for the diagnosis of multiple sclerosis. The recommended method for qualitative detection of oligoclonal IgM bands is electrophoresis or isoelectric focusing of unconcentrated CSF and subsequent immunodetection.4' Intrathecal production has been found, by quantitative and qualitative assays, in only 30% to 60% of patients with multiple sclerosis and thus seems to be of less value than detection of oligoclonal IgG bands. A degree of clinical relevance of IgM estimation has been reported due to its decrease with duration of the disease process43 and conversely, being more common with early exacerbations of the disease. 44 45 Further collaborative work is required to ascertain correlations between clinical variables and other CSF indices including myelin basic protein. The problem of a complicated quality control in cytology could be solved by sending sets of cytological slide preparations to different laboratories.
Proficiency testing in CSF analysis should also consider the control of the quality of data interpretation by including the five different focusing patterns50 that have been widely recognised in our collaborative studies of "blind" CSF samples (data not shown).
COSTS
The costs vary from around £25 to £90 per profile for the four tests listed in table 1. There seem to be three major variables that contribute to these costs: (1) technician time: beyond the basic costs for various labour intensive techniques, there may even be on call payments-for example, in the case of cell counting; (2) reagents: these are divided mainly between the more expensive commercial preparations that are available for the various tests as opposed to the much more economical "home-brewed" reagent kits; (3) interpretation: this depends largely on the analyst having the necessary degree of experience required to recognise the five basic patterns.
LETTER

Minor head injury: do you get what you expect?
Having read the study of Whittaker et al 1 concerning expectations and beliefs as predictors of recovery from minor head injury, one appreciates that this is an exciting time in the epidemiological research of these types of disorders. That is, minor head injury, whiplash injury, low back pain and related controversial disorders associated with chronic pain and disability have long been approached with a biopsychosocial model. Furthermore, although more and more studies, especially in the area of whiplash, reveal that the bio component is the least relevant, the ongoing problem has been to determine where to look for the psychosocial component. The common and fertile ground for all these disorders appears to be patient-held beliefs and, as an aspect of those beliefs, their expectations. In a longitudinal cohort study of patients with minor head injury, Whittaker et al found that patients who believe that their symptoms have serious negative consequences on their lives and will continue to do so are at heightened risk of experiencing significant enduring postconcussional symptoms. Notably, severity of the postconcussion symptoms in the initial postinjury period was not an independent predictor of outcome. Instead, the interpretation of their symptoms as serious and enduring is what puts patients at risk for chronic symptoms.
Parallel results have been found in other disorders. For individuals with whiplash injury, for example, in a population-based cohort of >6000 participants, after adjusting for the effect of sociodemographic characteristics, postcrash symptoms and pain, previous health status and collision-related factors, those who expected to get better soon recovered more than three times as quickly (hazard rate ratio 3.62; 95% confidence interval 2.55 to 5.13) as those who expected that they would never get better. 2 Findings were similar for resolution of painrelated limitations and resolution of neckpain intensity. In brief, controlling for initial pain, symptoms, sex, age and numerous other baseline variables, the answer to the single question early after injury "Do you think that your injury will get better soon; get better slowly; never get better; or don't know?" is a stronger predictor of recovery rate than any psychosocial variable we have ever investigated in whiplash cohorts. Expectations and beliefs also predict the likelihood of returning to work after whiplash injury 3 and predict chronicity after low back injury. What is most interesting and concerning about expectations and beliefs that predict these outcomes is that these expectations and beliefs are highly prevalent in the general population, even in those who have not experienced the disorders before. It has been shown, for example, that negative beliefs about neck pain, upper extremity injury and whiplash injury, in particular, are common in a Canadian population. 9 As well, among Canadian participants who have themselves not experienced a minor head injury nor have an immediate family member who has had this injury, 50% expect that chronic symptoms should follow the injury. 10 The relevance of this area of research is further highlighted by the observation that in countries where a minor head injury has a much better prognosis than in, say, Western countries, these expectations are uncommon or rare.
11 12 Whittaker et al are conducting research on minor head injury in the direction it needs to go if we are ever to build a model accurate enough to plan interventions that will prevent patients from getting what they expect.
Moreover, Whittaker et al provide clues to preventive interventions that may improve outcomes and considerably reduce healthcare costs in a range of disorders that are common and costly. Negative beliefs and expectations for common conditions such as minor head injury, low back pain and whiplash injury are highly prevalent and also very expensive. In Australia, approximately US$10 million was spent on a social marketing campaign designed to alter the population beliefs about low back pain. The program was effective, and it was cost-effective, with improvements in both population and healthcare provider beliefs about back pain observed after the campaign, along with dramatic reductions in work-related disability and healthcare visits. PAW35 Anti-prion protein monoclonal antibodies at low doses effectively treat prion disease in mice without side-effects. In this abstract the author order was incorrect, it should be C Carswell, R Drynda, S Martins, A Clarke, S Brandner, S Mead, J Collinge, A Khalili-Shirazi. Also the corresponding author is j.collinge@prions. ucl.ac.uk.
